malaria

5 · 20 / page

Ask MedXY AI

Latest news

Tag

Infectious Diseasesivermectinmalaria

Dual-Purpose Public Health: Ivermectin Mass Drug Administration Reduces Malaria Incidence and Scabies Prevalence

By MedXY|Jan 13, 2026

Large-scale trials in Kenya and Mozambique demonstrate that ivermectin mass drug administration significantly reduces malaria incidence by 26% and lowers community scabies prevalence, providing both direct protection and indirect herd-like

Human Monoclonal Antibody MAM01 for Malaria Prevention: Phase 1 Trial Insights and Context in Antimalarial Monoclonal Antibody Development

Clinical Updatesclinical trialmalaria

malaria

Latest news

Dual-Purpose Public Health: Ivermectin Mass Drug Administration Reduces Malaria Incidence and Scabies Prevalence

Human Monoclonal Antibody MAM01 for Malaria Prevention: Phase 1 Trial Insights and Context in Antimalarial Monoclonal Antibody Development

GanLum (KLU156): A New Class of Antimalarial Showing 97.4% PCR‑Corrected Cure in Phase III

Seasonal Malaria Chemoprevention in Uganda: Efficacy of SPAQ and Dihydroartemisinin-Piperaquine in the Era of Drug Resistance

Mass Ivermectin Administration for Malaria Control: Translational Insights from Recent Cluster-Randomized Trials